GENRX ROXITHROMYCIN roxithromycin 150 mg film coated tablets blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

roxithromycin, Quantity: 150 mg

Saatavilla:

Arrotex Pharmaceuticals Pty Ltd

INN (Kansainvälinen yleisnimi):

Roxithromycin

Lääkemuoto:

Tablet, film coated

Koostumus:

Excipient Ingredients: hyprolose; purified talc; maize starch; glucose; colloidal anhydrous silica; sodium starch glycollate type A; sodium starch glycollate type B; titanium dioxide; hypromellose; magnesium stearate; povidone; propylene glycol; poloxamer

Antoreitti:

Oral

Kpl paketissa:

10 tablets

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Adults: Roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. Skin and skin structure infections. Nongonococcal urethritis. Children: ROXITHROMYCIN 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible microorganisms: Acute pharyngitis. Acute tonsillitis, impetigo. Appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. Therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Tuoteyhteenveto:

Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2008-04-10